Health

FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults

DailyTrendDailyTrend
Aug 4, 2025 - 20:00
 0  0
FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults
Greenville, SC – July 31, 2025 – Rosemont Pharmaceuticals, Inc. announced that on July 23, 2025, the U.S. Food and Drug Administration (FDA) has approved Vostally (ramipril) Oral Solution, an angiotensin converting enzyme (ACE) inhibitor...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the F...

DailyTrend Jul 30, 2025  0  0

FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use: Drug Safety Communication

FDA is Requiring Opioid Pain Medicine Manufacturers to ...

DailyTrend Aug 4, 2025  0  0

Major Study on Transgender Youth Health Care to Begin in U.K.

Major Study on Transgender Youth Health Care to Begin i...

DailyTrend Jul 31, 2025  0  0

FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors

FDA Approves Alhemo as Once-Daily Prophylactic Treatmen...

DailyTrend Aug 3, 2025  0  0

Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Sobi Announces U.S. Food and Drug Administration Approv...

DailyTrend Jul 29, 2025  0  0

New Implant Offers Hope for Easing Rheumatoid Arthritis

New Implant Offers Hope for Easing Rheumatoid Arthritis

DailyTrend Jul 31, 2025  0  0